Abstract
Rationale
Recent reports on the abuse of novel synthetic cathinone derivatives call attention to serious public health risks of these substances. In response to this concern, a growing body of preclinical research has characterized the psychopharmacology of these substances, particularly mephedrone (MEPH) or methylenedioxypyrovalerone (MDPV), noting their similarities to 3,4-methylenedioxymethamphetamine (MDMA) and cocaine. Few studies have utilized drug discrimination methodology to characterize the psychopharmacological properties of these substances.
Objectives
The present study employed a rodent drug discrimination assay to further characterize the stimulus effects of MEPH and MDPV in comparison to MDMA and to a drug mixture comprised of d-amphetamine and MDMA.
Methods
Eight male Sprague-Dawley rats were trained to discriminate 1.5 mg/kg MDMA, and eight rats were trained to discriminate a mixture of 1.5 mg/kg MDMA and 0.5 mg/kg d-amphetamine (MDMA + AMPH) from vehicle. Substitution tests were conducted with MDMA, d-amphetamine, MDPV, MEPH, and cocaine.
Results
Dose-response curves generated with MDMA and MEPH were comparable between training groups. In contrast, AMPH, MDPV, and cocaine produced only partial substitution in animals trained to discriminate MDMA but produced full substitution in animals trained to discriminate the MDMA + AMPH mixture.
Conclusions
These findings indicate that MDPV’s effects may be more similar to those of traditional psychostimulants, whereas MEPH exerts stimulus effects more similar to those of MDMA. Additional experiments with selective DA and 5-hydroxytryptamine (5-HT) receptor antagonists are required to further elucidate specific receptor mechanisms mediating the discriminative stimulus effects of MDPV and mephedrone.
Similar content being viewed by others
References
Aarde SM, Angrish D, Barlow DJ, Wright MJ Jr, Vandewater SA, Creehan TMA et al (2013a) Mephedrone (4-methylmeth-cathinone) supports intravenous self-administration in Sprague–Dawley and Wistar rats. Addict Biol 18(5):786–799. doi:10.1111/adb.12038
Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA (2013b) The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71:130–140. doi:10.1016/j.neuropharm.2013.04.003
Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF, Cozzi NV et al (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37(5):1192–1203. doi:10.1038/npp.2011.304
Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Schindler CW et al (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products. Neuropsychopharmacology 38:552–562
Berquist MD II, Peet MM, Baker LE (2015) Behavioral sensitization following concurrent exposure to mephedrone and d-amphetamine in female mice. Behav Pharmacol 26:180–183. doi:10.1097/FBP.0000000000000121
Cameron K, Kolanos R, Verkariya R, Felice L, Glennon R (2013) Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of “bath salts”, produce opposite effects at the human dopamine transporter. Psychopharmacology 227(3):493–499. doi:10.1007/s00213-013-2967-2
Campbell A (2012) Carl Jacquneaux bit a chunk of face off victim Todd Credeur in Louisiana, cops say. The Huffington Post. Retrieved from http://www.huffingtonpost.com/2012/06/06/carl-jacquneaux-bit-a-chunk-of-victims-face_n_1574316.html
Carhart-Harris RI, King LA, Nutt DJ (2011) A web-based survey on mephedrone. Drug Alcohol Depend 118(1):19–22. doi:10.1016/j.drugalcdep.2011.02.011
Dal Cason T, Young R, Glennon R (1997) Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs. Pharmacol Biochem Behav 58(4):1109–1116. doi:10.1016/S0091-3057(97)00323-7
Drug Enforcement Administration (DEA) (2011) Schedules of controlled substances: temporary placement of three synthetic cathinones into schedule I. In: Federal Register 76:204. U.S. Government Printing Office, Washington, DC
Fantegrossi W, Gannon B, Zimmerman S, Rice K (2013) In vivo effects of abused ‘bath salt’ constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. Neuropsychopharmacology 38(4):563–573
Gatch M, Taylor C, Forster M (2013) Locomotor stimulant and discriminative stimulus effects of ‘bath salt’ cathinones. Behav Pharmacol 24(5–6):437–447
Gibbons S, Zloh M (2010) An analysis of the ‘legal high’ mephedrone. Bioorg Med Chem Lett 20(14):4135–4139. doi:10.1016/j.bmcl.2010.05.065
Goodnough A, Zezima K (2011) An alarming new stimulant, legal in many states. The New York Times. http://www.nytimes.com/2011/07/17/us/17salts.html. Accessed 7 Nov 2014
Goodwin A, Baker L (2000) A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (±)-MDMA in rats. Exp Clin Psychopharmacol 8(3):415–423. doi:10.1037/1064-1297.8.3.415
Goodwin A, Pynnonen D, Baker L (2003) Serotonergic–dopaminergic mediation of MDMA’s discriminative stimulus effects in a three-choice discrimination. Pharmacol Biochem Behav 74(4):987–995. doi:10.1016/S0091-3057(03)00029-7
Gregg R, Tallarida C, Reitz A, Mccurdy C, Rawls S (2013a) Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats. Drug Alcohol Depend 133(2):746–750
Gregg R, Tallarida C, Reitz A, Rawls S (2013b) Mephedrone interactions with cocaine: prior exposure to the ‘bath salt’ constituent enhances cocaine-induced locomotor activation in rats. Behav Pharmacol 24(8):684–688. doi:10.1097/FBP.0000000000000006
Huang P, Aarde S, Angrish D, Houseknecht K, Dickerson T, Taffe M (2012) Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypy-rovalerone, and 4-methylmethcathinone on wheel activity in rats. Drug Alcohol Depend 126(1–2):168–175
Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F, Yoshitake T (2011) Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol 164(8):1949–1958
Khorana N, Pullagurla M, Young R, Glennon R (2004) Comparison of the discriminative stimulus effects of 3,4-methylenedioxymetha-mphetamine (MDMA) and cocaine: asymmetric generalization. Drug Alcohol Depend 74(3):281–287. doi:10.1016/j.drugalcdep.2004.01.005
Kueh D, Baker L (2007) Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine. Psychopharmacology 189(4):447–457. doi:10.1007/s00213-006-0523-z
Lisek R, Xu W, Yuvasheva E, Chiu Y, Reitz A, Liu-Chen L, Rawls S (2012) Mephedrone (‘bath salt’) elicits conditioned place preference and dopamine-sensitive motor activation. Drug Alcohol Depend 126(1–2):257–262
Miyazawa M, Kojima T, Nakaji S (2011) Behavioral and rewarding effects of methylone, an analog of MDMA in mice. Hirosaki Med J 62(1):56–71
Motbey CP, Hunt GE, Bowen MT, Artiss S, McGregor IS (2012) Mephedrone (4-methylmethcathinone, ‘meow’): acute behavioural effects and distribution of Fos expression in adolescent rats. Addict Biol 17:409–422. doi:10.1111/j.1369-1600.2011.00384.x
National Research Council of the National Academies (2011) Guide for the care and use of laboratory animals. The National Academies Press, Washington, D. C
Nicholson KL, Balster RL (2001) GHB: a new and novel drug of abuse. Drug Alcohol Depend 63(1):1–22. doi:10.1016/S0376-8716(00)00191-5
Police: Man on bath salts runs naked down street (2013) Altoona mirror. http://www.altoonamirror.com/page/content.detail/id/569536/Police--Man-on-bath-salts-runs-naked-down-street.html?nav=742. Accessed 19 Mar 2013
Rosenbaum C, Carreiro S, Babu K (2012) Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, spice), synthetic cathinones (bath salts), kratom, salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 8(1):15–32
Shoaib M, Baumann MH, Rothman RB, Goldberg SR, Schindler CW (1997) Behavioural and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats. Psychopharmacology 131(3):296–306
Shortall S, Macerola A, Swaby R, Jayson R, Korsah C, Pillidge K, King M et al (2013) Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat. Eur Neuropsychopharmacol 23(9):1085–1095. doi:10.1016/j.euroneuro.2012.09.005
Stolerman I (2011) The discrimination of drug mixtures. In: Glennon R, Young R (eds) Drug discrimination: applications to medicinal chemistry and drug studies, 1st edn. Wiley, Hoboken, pp 323–359
Stolerman I, Childs E, Ford M, Grant K (2011) Role of training dose in drug discrimination. Behav Pharmacol 22(5–6):415–429. doi:10.1097/FBP.0b013e328349ab37
Varner K, Daigle K, Weed P, Lewis P, Mahne S, Sankaranarayanan A, Winsauer P (2013) Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats. Psychopharmacology 225(3):675–685
Winstock AR, Ramsey JD (2010) Legal highs and the challenges for policy makers. Addiction 105(10):1685–1687
Wright MJ Jr, Angrish D, Aarde SM, Barlow DJ, Buczynski MW, Creehan KM, Taffe MA et al (2012) Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague–Dawley rats. PLoS One 7(8), e44652. doi:10.1371/journal.pone.0044652
Young R (2009) Drug discrimination. In: Buccafusco JJ (ed) Methods of behavior analysis in neuroscience, 2nd edn. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK5225/
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harvey, E.L., Baker, L.E. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture. Psychopharmacology 233, 673–680 (2016). https://doi.org/10.1007/s00213-015-4142-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-015-4142-4